Breaking through barriers.
Advancing transformative treatments.


Voyager envisions a world in which transformative treatments and cures are available to the millions afflicted with neurological diseases.


To create disease-modifying neurogenetic medicines by identifying validated targets, advancing multiple therapeutic modalities, and delivering to the right areas within the central nervous system.

Voyager’s leaders bring deep expertise in biopharmaceutical development, neurotherapeutics, genetic medicines, strategic management, and organizational culture. The result is a company delivering on its breakthroughs.

Patients First.

Better Together.

Transformative Innovation.

Disciplined Execution.